Viral Interference of Hepatitis C and E Virus Replication in Novel Experimental Co-Infection Systems

Background: Hepatitis C virus (HCV) constitutes a global health problem, while hepatitis E virus (HEV) is the major cause of acute viral hepatitis globally. HCV/HEV co-infections have been poorly characterized, as they are hampered by the lack of robust HEV cell culture systems. This study developed...

Full description

Bibliographic Details
Published in:	Cells
Main Authors:	Thomas Burkard, Nora Proske, Kathrin Resner, Laura Collignon, Leonard Knegendorf, Martina Friesland, Lieven Verhoye, Ibrahim M. Sayed, Yannick Brüggemann, Maximilian K. Nocke, Patrick Behrendt, Heiner Wedemeyer, Philip Meuleman, Daniel Todt, Eike Steinmann
Format:	Article
Language:	English
Published:	MDPI AG 2022-03-01
Subjects:	Hepatitis C virus (HCV) Hepatitis E virus (HEV) co-infection human hepatocytes sofosbuvir HCV protease
Online Access:	https://www.mdpi.com/2073-4409/11/6/927

Similar Items

A novel in vitro system for simultaneous infections with hepatitis B, C, D and E viruses
by: Roxanne Fouillé, et al.
Published: (2025-05-01)

A preregistered meta-meta-analysis on the global distribution of Hepatotropic Viruses
by: Shuaibu Suleiman Adeiza, et al.
Published: (2024-11-01)

Hepatitis C virus genotypes and viremia in a tertiary hospital in Istanbul, Turkey
by: Sema Alacam, et al.
Published: (2022-04-01)

Advances in the Elimination of Viral Hepatitis in Mexico: A Local Perspective on the Global Initiative
by: Gerardo Santos-López, et al.
Published: (2024-10-01)

A Telementoring Program and Hepatitis C Virus Care in Rural Patients
by: Ping Du, et al.
Published: (2021-05-01)

Low intrafamilial transmission of hepatitis C virus in Central Brazil
by: R. M. B. Martins, et al.
Published: (1994-12-01)

HCV core antigen is an alternative marker to HCV RNA for evaluating active HCV infection: implications for improved diagnostic option in an era of affordable DAAs
by: Rujipat Wasitthankasem, et al.
Published: (2017-11-01)

Antiviral Activity of Zinc Oxide Nanoparticles and Tetrapods Against the Hepatitis E and Hepatitis C Viruses
by: Jyoti Gupta, et al.
Published: (2022-06-01)

HCV RNA positivity among hepatitis C patients in Chongqing, China from 2004 to 2021: a cross-sectional study
by: Yaping He, et al.
Published: (2024-11-01)

Occult hepatitis C virus infection in Iranian hemodialysis patients
by: Ali Eslamifar, et al.
Published: (2015-10-01)

Evaluation of Two-Assay Serological Testing Strategies for Anti-HCV Screening in Italian Populations: A Dual Screening Approach
by: Elena Zocca, et al.
Published: (2024-03-01)

Cryoglobulinemia and hepatitis C virus
by: N. V. Dunaeva, et al.
Published: (2014-09-01)

Identification of Keratin 23 as a Hepatitis C Virus-Induced Host Factor in the Human Liver
by: Volker Kinast, et al.
Published: (2019-06-01)

HCV related severe cryoglobulinemic vasculitis treated with plasma exchange and rituximab: case report and literature review
by: Snezana Arandjelovic, et al.
Published: (2017-06-01)

Hepatitis C-related knowledge and attitude among adults on probation in a large US city
by: Matthew S. Minturn, et al.
Published: (2024-07-01)

The Utility of ANTI-HCV S/CO Ratio, HCV-RNA and ALT Test in Predicting Viremia in ANTI-HCV Positive Patients
by: Tuğrul Himmetoğlu, et al.
Published: (2007-07-01)

Evaluation of an enzyme immunoassay for hepatitis C virus antibody detection using a recombinant protein derived from the core region of hepatitis C virus genome
by: EPA Lopes, et al.
Published: (2000-10-01)

Hepatitis C genotype 4: Genotypic diversity, epidemiological profile, and clinical relevance of subtypes in Saudi Arabia
by: Hamad I Al Ashgar, et al.
Published: (2013-01-01)

Prevalence of anti-hepatitis C virus antibodies in pregnant women and their offspring in a tertiary hospital in Southwestern Nigeria
by: Paul Sunday Ogunro, et al.
Published: (2007-12-01)

FEATURES OF CIRCULATION OF HEPATITIS C VIRUS IN KHABAROVSK REGION
by: N. V. Soboleva, et al.
Published: (2017-06-01)

Immunological and Virological Responses in Patients with Monoinfection and Coinfection with Hepatitis B and C Viruses in the Brazilian Amazon
by: Joseane R. Silva, et al.
Published: (2025-06-01)

Diagnostic approach to elucidate the efficacy and side effects of direct-acting antivirals in HCV infected patients
by: Sonia Younas, et al.
Published: (2021-10-01)

Global Real-World Evidence of Sofosbuvir/Velpatasvir as a Highly Effective Treatment and Elimination Tool in People with Hepatitis C Infection Experiencing Mental Health Disorders
by: Heiner Wedemeyer, et al.
Published: (2022-11-01)

Telehealth as an Important Player in the Management of Hepatitis C Virus
by: Adeel Khoja, et al.
Published: (2021-04-01)

Pathway to hepatitis C elimination: insights from a large tertiary hospital in South China
by: Suling Chen, et al.
Published: (2025-12-01)

Threshold value of the anti-HCV test in the diagnosis of HCV infection
by: Özlem Kirişci, et al.
Published: (2019-10-01)

Hepatitis C Virus Infection in Eastern Libya: Efforts Needed to Improve HCV Testing and Linkage to Care in the Resource-Limited Setting
by: Faisal Ismail, et al.
Published: (2022-01-01)

The prevalence of the hepatitis C virus among the conditionally healthy population of the Russian Federation
by: N. V. Soboleva, et al.
Published: (2017-06-01)

Late Relapse and Reinfection in HCV Patients Treated with Direct-Acting Antiviral (DAA) Drugs
by: Claudia Minosse, et al.
Published: (2021-06-01)

The Advancement of Nanomaterials for the Detection of Hepatitis B Virus and Hepatitis C Virus
by: Wanting Shi, et al.
Published: (2023-10-01)

Concurrent Infection with Hepatitis C Virus and Streptococcus pneumoniae
by: Thomas J. Marrie, et al.
Published: (2017-07-01)

Safety and efficacy of directly acting antivirals (sofosbuvir and daclatasvir) in treatment of chronic HCV in HIV-HCV co-infected Egyptian patients
by: Inas E L-Khedr Mohamed, et al.
Published: (2021-04-01)

Treatment of hepatitis C virus infection in the future
by: Tatsuo Kanda, et al.
Published: (2013-12-01)

Screening for Hepatitis C Virus Reinfection Using a Behaviour-Based Risk Score among Men Who Have Sex with Men with HIV: Results from a Case–Control Diagnostic Validation Study
by: Kris Hage, et al.
Published: (2023-10-01)

Prevalence of hepatitis C virus infection and associated factors among male illicit drug users in Cuiabá, Mato Grosso, Brazil
by: Antônia Carlos Magalhães Novais, et al.
Published: (2009-09-01)

Hepatitis C Virus Elimination Program among Prison Inmates, Israel
by: Lihi Eisen, et al.
Published: (2023-11-01)

Development of an Ex Vivo Assay for Identification of Infectious Hepatitis E Virus in Different Kinds of Food Samples
by: Renate W. Hakze-van der Honing, et al.
Published: (2023-10-01)

The prevalence of hepatitis B infection and anti‐HCV antibody in patients with diabetes mellitus
by: Malihe Naderi, et al.
Published: (2025-09-01)

Serological, epidemiological and molecular aspects of hepatitis C virus infection in a population from Londrina, PR, Brazil, 2001-2002 Aspectos sorológicos, epidemiológicos e moleculares da infecção pelo vírus da hepatite C na população da região de Londrina, Paraná, Brasil, 2001-2002
by: Ingridt Hildegard Vogler, et al.
Published: (2004-04-01)

Survey of Hepatitis B and C Among Employees of University of Sindh, Pakistan; Focus on Risk Factors and Lack of Treatment Due to Low Socio-Economic Status
by: Afsheen Mushtaque Shah, et al.
Published: (2020-12-01)